国际肿瘤学杂志 ›› 2017, Vol. 44 ›› Issue (8): 590-593.doi: 10.3760/cma.j.issn.1673-422X.2017.08.008

• 综述 • 上一篇    下一篇

内质网-自噬途径在肿瘤耐药中的研究现状

孙王宏,王海峰,杨德林   

  1. 650101昆明医科大学第二附属医院泌尿外科
  • 出版日期:2017-08-08 发布日期:2017-07-21
  • 通讯作者: 杨德林,Email: ydelin@163.com E-mail:ydelin@163.com
  • 基金资助:

    国家自然科学基金(81660422、81460385)

Research status of endoplasmic reticulumautophagy pathway in drug resistance of tumor

Sun Wanghong, Wang Haifeng, Yang Delin   

  1. epartment of Urology Surgery, Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China
  • Online:2017-08-08 Published:2017-07-21
  • Contact: Yang Delin, Email: ydelin@163.com E-mail:ydelin@163.com
  • Supported by:

    National Natural Science Foundation of China (81660422, 81460385)

摘要: 自噬在肿瘤治疗中扮演着双重角色。多数化疗药物能够通过激活内质网应激来诱导肿瘤细胞自噬,过度激活的自噬能够造成肿瘤细胞凋亡,发挥抗肿瘤作用。自噬对肿瘤细胞又具有保护作用,它能够通过对破损细胞器的降解再利用,维持肿瘤细胞活性,降低对化学药物的敏感性。因此,促进或抑制自噬的调节剂联合化疗药物在肿瘤治疗中将具有发展潜力。

关键词: 内质网, 自噬, 抗药性, 肿瘤, 应激

Abstract: Autophagy plays a dual role in tumor therapy. A variety of chemotherapy drugs can induce tumor autophagy by activating endoplasmic reticulum stress, and hyperactive autophagy can cause tumor cell apoptosis and plays an antitumor effect. Autophagy has a protective effect on tumor cells, which can maintain the survival of tumor cells and reduce the sensitivity of chemotherapy drugs by reusing the degradation of the damaged organelles. Therefore, the promotion or inhibition of autophagy modulators combined with chemotherapy drugs will have the potential for development in tumor therapy.

Key words: Endoplasmic reticulum, Autophagy, Drug resistance, neoplasm, Stress